Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current issues in cancer. Biological therapy.

× No keyword cloud information.

12 in total

Review 1. Biological therapies.

Authors: A Jones; P Selby
Journal: Radiother Oncol Date: 1991-04 Impact factor: 6.280

2. Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin.

Authors: C J Honsik; G Jung; R A Reisfeld
Journal: Proc Natl Acad Sci U S A Date: 1986-10 Impact factor: 11.205

Review 3. Emerging clinical uses for GM-CSF.

Authors: J H Scarffe
Journal: Eur J Cancer Date: 1991 Impact factor: 9.162

4. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

Authors: G Hale; M J Dyer; M R Clark; J M Phillips; R Marcus; L Riechmann; G Winter; H Waldmann
Journal: Lancet Date: 1988-12-17 Impact factor: 79.321

5. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.

Authors: J Crawford; H Ozer; R Stoller; D Johnson; G Lyman; I Tabbara; M Kris; J Grous; V Picozzi; G Rausch
Journal: N Engl J Med Date: 1991-07-18 Impact factor: 91.245

6. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

Authors: F Mandelli; G Avvisati; S Amadori; M Boccadoro; A Gernone; V M Lauta; F Marmont; M T Petrucci; M Tribalto; M L Vegna
Journal: N Engl J Med Date: 1990-05-17 Impact factor: 91.245

Review 7. Tumour necrosis factor: clinical relevance.

Authors: A L Jones; P Selby
Journal: Cancer Surv Date: 1989

8. Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.

Authors: S Wadler; B Lembersky; M Atkins; J Kirkwood; N Petrelli
Journal: J Clin Oncol Date: 1991-10 Impact factor: 44.544

9. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.

Authors: M Talpaz; H M Kantarjian; K McCredie; J M Trujillo; M J Keating; J U Gutterman
Journal: N Engl J Med Date: 1986-04-24 Impact factor: 91.245

Review 10. The cytokine network.

Authors: F R Balkwill; F Burke
Journal: Immunol Today Date: 1989-09